Axite has secured €250,000 in Takeoff 2 early-stage funding, a significant step forward in their journey of innovation and growth. Meanwhile, 1NA has been honored with the prestigious 2025 CES Innovation Award, recognizing their outstanding contributions to technology and health.
These milestones reflect the spirit of ambition and innovation that defines our Leiden Bio Science Park community. Congratulations to both teams—here’s to an exciting future ahead!.
Leiden, the Netherlands, May 26th 2026 – VitroScan, a biotechnology company pioneering predictive ex vivo tumor testing, today announced the start of a joint project with scientists from the Radboudumc to advance the development of novel cell therapies for the treatment of ovarian cancer. Ovarian cancer…
